224 related articles for article (PubMed ID: 35688675)
21. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
22. Ectropion Uveae in neurofibromatosis type 1: a new manifestation.
Iacovino C; Miraglia E; Moramarco A; Corbo G; Lambiase A; Giustini S
Clin Ter; 2021 May; 172(3):206-208. PubMed ID: 33956037
[TBL] [Abstract][Full Text] [Related]
23. [Plexiform neurofibroma of the bladder associated with neurofibromatosis type 1: a case report].
Nakazawa S; Yoneda S; Takezawa K; Tanigawa G; Fujita K; Okumi M; Hosomi M; Fukuhara S; Fushimi H; Yamaguchi S
Hinyokika Kiyo; 2012 Apr; 58(4):215-8. PubMed ID: 22684263
[TBL] [Abstract][Full Text] [Related]
24. A fortuitous discovery of a neurofibroma in a female patient with type 1 neurofibromatosis: a case report.
Harrabi F; Methnani J; Houssem A; Abdelkader M; Mehdi BL; Amine SM; Mohamed BM; Ali BA
J Int Med Res; 2022 Dec; 50(12):3000605221139716. PubMed ID: 36510447
[TBL] [Abstract][Full Text] [Related]
25. Exuberant manifestation of neurofibromatosis type 1 affecting 3 generations: delayed diagnosis and the importance of the multidisciplinary approach.
Tolentino ES; Souza Pinto GN; Maciel L; Soares CT; Lara VS; Moreschi ARC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):e108-e112. PubMed ID: 31101459
[TBL] [Abstract][Full Text] [Related]
26. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
[TBL] [Abstract][Full Text] [Related]
27. Von recklinghausen neurofibromatosis-pachydermatocele causing lower limb gigantism: a case report.
Rekha A; Gopalan TR
Int J Low Extrem Wounds; 2006 Mar; 5(1):61-3. PubMed ID: 16543214
[TBL] [Abstract][Full Text] [Related]
28. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
29. [Imaging features of neurofibromatosis type 1].
Jacques C; Dietemann JL
J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
[TBL] [Abstract][Full Text] [Related]
30. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
[TBL] [Abstract][Full Text] [Related]
32. Laryngeal plexiform neurofibroma in a child.
Kasapoglu F; Ozdemircan T; Erisen L
Ear Nose Throat J; 2013 Jun; 92(6):E31. PubMed ID: 23780601
[TBL] [Abstract][Full Text] [Related]
33. Café-au-lait macules: occasional fatal sequels of benign pigmented lesions.
Fernandez-Flores A; Orduña O; Aguirrezabal M
Acta Dermatovenerol Croat; 2008; 16(2):79-82. PubMed ID: 18541103
[TBL] [Abstract][Full Text] [Related]
34. Mosaic Neurofibromatosis Type 1 in Children: A Single-Institution Experience.
Lara-Corrales I; Moazzami M; García-Romero MT; Pope E; Parkin P; Shugar A; Kannu P
J Cutan Med Surg; 2017; 21(5):379-382. PubMed ID: 28448720
[TBL] [Abstract][Full Text] [Related]
35. A novel NF1 mutation in a pediatric patient with renal artery aneurysm.
Chillura I; Restivo GA; Callari S; Cibella S; D'Alessandro MM; Corrado C; Vallone M; Antona V; Corsello G
Ital J Pediatr; 2022 Nov; 48(1):186. PubMed ID: 36411470
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2.
Plana-Pla A; Bielsa-Marsol I; Carrato-Moñino C;
Actas Dermosifiliogr; 2017 Sep; 108(7):630-636. PubMed ID: 28237041
[TBL] [Abstract][Full Text] [Related]
37. Congenital cutaneous neurofibromas in neurofibromatosis type 1: Clinicopathological features in early infancy.
García-Martínez FJ; Azorín D; Duat-Rodríguez A; Hernández-Martín Á
J Dtsch Dermatol Ges; 2021 Jan; 19(1):73-80. PubMed ID: 33448128
[TBL] [Abstract][Full Text] [Related]
38. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
[TBL] [Abstract][Full Text] [Related]
39. [Unusual clinical manifestations of type 1 neurofibromatosis].
Komlósi K; Polgár N; Hadzsiev K; Ottóffy G; Illés T; Dóczi T; Melegh B
Orv Hetil; 2011 Dec; 152(49):1965-70. PubMed ID: 22106164
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
García-Martínez FJ; Hernández-Martín A
Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
